Oklahoma Administrative Code
Title 195 - Board of Dentistry
Chapter 20 - Rules Governing the Administration of Anesthesia
Section 195:20-1-3.1 - Pediatric conscious sedation utilizing enteral methods (oral, rectal, sublingual)

(a) Required training. Every dentist who administers pediatric conscious sedation using enteral methods (includes oral, rectal, sublingual) or minor tranquilizers in anxiolytic dosages to dental patients ages twelve (12) years and under must satisfy at least one of the following requirements:

(b) Permit for Dentists. No dentist shall administer pediatric conscious sedation using enteral methods (includes oral, rectal, sublingual) or minor tranquilizers in anxiolytic dosages for dental patients ages twelve (12) and under unless such dentist possesses a permit or authorization issued by the Oklahoma Board of Dentistry for the administration of pediatric conscious sedation using enteral methods. Application for such permit will be made to the Board on the prescribed form. A successful credentials review will result in a notification that a formal evaluation can be scheduled. The dentist holding such permit shall be subject to review and such permit must be renewed annually, along with payment of the required fee.

(c) Current training. A dentist who holds a permit for pediatric enteral conscious sedation shall satisfy all of the following:

(d) Facility Permit Inspections. Each facility of every dentist who authorizes the administration of pediatric enteral conscious sedation (includes oral, rectal, sublingual) or minor tranquilizers in anxiolytic dosages in his or her office to dental patients ages twelve (12) years and under shall successfully pass inspection by a consultant or consultants appointed by the Board. This will include an evaluation of the facility's equipment and personnel and will follow the American Dental Association's Guidelines for the Use of Conscious Sedation, Deep Sedation, and General Anesthesia in Dentistry. This evaluation will be on a prescribed form approved by the Board and be available to the applicant for review prior to a request for an inspection. Such dentist is permitted to work with or employ:

(e) Provider Permit Inspections. The knowledge, techniques, procedures, facilities, drugs, equipment and personnel utilization of every dentist who administers pediatric enteral conscious sedation or minor tranquilizers in anxiolytic dosages shall successfully pass inspection by a consultant or consultants appointed by the Board. This evaluation will be completed on a prescribed form approved by the Board and be available to the applicant for review prior to an inspection. This form shall follow the American Dental Association Guidelines for the Use of Conscious Sedation Deep Sedation and General Anesthesia in Dentistry. New provider permit applicants will not be required to demonstrate the administration of pediatric enteral conscious sedation to a minor patient in the presence of an evaluation team unless requested to do so at the Board's discretion. In the case of a mobile or portable dentist provider, all inspections of that provider shall be conducted in the office of an Oklahoma licensed dentist where pediatric enteral conscious sedation is administered.

(f) Direct Supervision of a Certified Registered Nurse Anesthetist (CRNA). A dentist is permitted to directly supervise the administration of pediatric enteral conscious sedation or minor tranquilizers in anxiolytic dosages to dental patients by a CRNA provided the following requirements are satisfied:

(g) Restrictions. No dentist providing pediatric enteral conscious sedation or minor tranquilizers in anxiolytic dosages to dental patients ages twelve (12) years and under shall administer or employ any agent(s) which has a narrow margin for maintaining consciousness and would likely render a patient deeply sedated, generally anesthetized or otherwise not meeting the conditions of the definition of conscious sedation stated in section 195:20-1-2. Oral administration of all short acting medications including but not limited to Versed® (Midazalam HCL) and Actiq® (oral transmucosal fentanyl) shall be performed on the dental premise only. Prescriptions for these drug therapies intended for at home pre-medication shall be prohibited.

(h) Exceptions.